Your browser doesn't support javascript.
loading
In vitro and in silico computational methods for assessing vaginal permeability.
Tsanaktsidou, Eleni; Krestenitis, Marios; Karavasili, Christina; Zacharis, Constantinos K; Fatouros, Dimitrios G; Markopoulou, Catherine K.
Afiliação
  • Tsanaktsidou E; Laboratory of Pharmaceutical Analysis, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Krestenitis M; Laboratory of Pharmaceutical Analysis, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Karavasili C; Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Zacharis CK; Laboratory of Pharmaceutical Technology, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Fatouros DG; Laboratory of Pharmaceutical Analysis, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Markopoulou CK; Laboratory of Pharmaceutical Technology, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Drug Dev Ind Pharm ; 49(3): 249-259, 2023 Mar.
Article em En | MEDLINE | ID: mdl-37014319
ABSTRACT

OBJECTIVE:

Vaginal administration is an important alternative to the oral route for both topical and systemic use. Therefore, the development of reliable in silico methods for the study of drugs permeability is becoming popular in order to avoid time-consuming and costly experiments.

METHODS:

In the current study, Franz cells and appropriate HPLC or ESI-Q/MS analytical methods were used to experimentally measure the apparent permeability coefficient (Papp) of 108 compounds (drugs and non-drugs). Papp values were then correlate with 75 molecular descriptors (physicochemical, structural, and pharmacokinetic) by developing two Quantitative Structure Permeability Relationship (QSPR) models, a Partial Least Square (PLS) and a Support Vector Machine (SVM). Both were validated by internal, external and cross-validation.

RESULTS:

Based on the calculated statistical parameters (PLS model A R2 = 0.673 and Q2 = 0.594, PLS model B R2 = 0.902 and Q2 = 0.631, SVM R2 = 0.708 and Q2 = 0.758). SVM presents higher predictability while PLS adequately interprets the theory of permeability.

CONCLUSIONS:

The most important parameters for vaginal permeability were found to be the relative PSA, logP, logD, water solubility and fraction unbound (FU). Respectively, the combination of both models could be a useful tool for understanding and predicting the vaginal permeability of drug candidates.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Relação Quantitativa Estrutura-Atividade Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Drug Dev Ind Pharm Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Relação Quantitativa Estrutura-Atividade Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Drug Dev Ind Pharm Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Grécia